title: Prolonged gastrointestinal dysmotility in a patient with hemophagocytic lymphohistiocytosis treated with vincristine.
authors.affiliation: Department of Pediatrics, Gunma University School of Medicine, Maebashi, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Tomomasa
authors.forename: R
authors.initials: R
authors.lastname: Miyazawa
authors.forename: M
authors.initials: M
authors.lastname: Kato
authors.forename: M
authors.initials: M
authors.lastname: Hoshino
authors.forename: M
authors.initials: M
authors.lastname: Tabata
authors.forename: H
authors.initials: H
authors.lastname: Kaneko
authors.forename: M
authors.initials: M
authors.lastname: Suzuki
authors.forename: T
authors.initials: T
authors.lastname: Kobayashi
authors.forename: A
authors.initials: A
authors.lastname: Morikawa
mesh_terms: D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects* / Q000627:therapeutic use; D001464:Barium; D002648:Child; D002908:Chronic Disease; D005471:Fluoroscopy; D005767:Gastrointestinal Diseases / Q000139:chemically induced* / Q000175:diagnosis / Q000503:physiopathology; D005769:Gastrointestinal Motility; D005772:Gastrointestinal Transit; D015616:Histiocytosis, Non-Langerhans-Cell / Q000188:drug therapy*; D006801:Humans; D007421:Intestine, Small / Q000378:metabolism; D008297:Male; D008365:Manometry; D014750:Vincristine / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D001464:Barium; D014750:Vincristine